Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatrics

Can Severe Newborn Jaundice Mean Hereditary Spherocytosis?

At a Glance

Severe, early, or prolonged jaundice in a newborn can be the first sign of hereditary spherocytosis. This genetic condition causes rapid red blood cell breakdown, leading to high bilirubin levels that require prompt treatment like phototherapy and close monitoring for anemia.

Yes, severe, early, or prolonged newborn jaundice can be the very first sign of hereditary spherocytosis (HS) [1][2]. While mild jaundice is very common in healthy newborns, babies with HS experience an accelerated breakdown of their red blood cells (hemolysis). This process releases large amounts of bilirubin (a yellow pigment) into the blood. Because a newborn’s liver is not yet fully developed, it cannot clear this pigment quickly enough, leading to a visible yellowing of the skin and eyes that can be significantly more severe than typical newborn jaundice [1].

In fact, HS is one of the most common causes of congenital (present at birth) hemolytic disease in newborns, though it is frequently underdiagnosed [1]. Recognizing it early is crucial for managing the jaundice safely and preparing for the baby’s future care needs [3].

How is HS Jaundice Different from Typical Newborn Jaundice?

Many full-term newborns develop “physiologic jaundice,” a normal phase that usually peaks between 3 to 5 days of life and clears up on its own within two weeks (though premature babies may have a slightly different timeline). Jaundice caused by hereditary spherocytosis behaves differently:

  • It often appears much earlier: Jaundice in a baby with HS may show up within the very first 24 hours of life.
  • It can be much more severe: Bilirubin levels can rise rapidly and be disproportionately high compared to the actual amount of red blood cells being destroyed [4].
  • It lasts longer: HS jaundice can be “prolonged,” meaning it persists beyond the typical 14-day window [2].
  • It can be worsened by other genes: Many babies who experience extremely severe jaundice with HS have also inherited a harmless, common genetic trait called Gilbert syndrome, which slows the liver’s ability to process bilirubin [4][5].

Treating Severe Jaundice in HS

Because very high levels of bilirubin can be dangerous and potentially cause neurological damage (a condition known as kernicterus), prompt and aggressive treatment is necessary. Fortunately, hospital treatments are highly effective at lowering bilirubin and preventing this damage when administered promptly:

  • Intensive Phototherapy: The baby is placed under special blue lights that change the bilirubin into a water-soluble form that the body can easily excrete. Babies with HS are more likely to require this treatment than infants with typical jaundice [6].
  • Exchange Transfusion: In extreme cases where bilirubin levels rise to dangerous heights despite phototherapy, an exchange transfusion may be needed [7][8]. This emergency procedure involves carefully replacing the baby’s blood with donor blood to rapidly remove bilirubin and the abnormal red blood cells.

Testing and Diagnosis: The Role of Genetic Testing (NGS)

If a newborn has severe, unexplained jaundice, doctors will look for the underlying cause. If a parent already knows they have HS, the diagnostic process is straightforward. However, if a baby is diagnosed without a known family history, it is generally recommended that the parents also undergo screening. Identifying the condition usually requires specialized tests:

  • EMA Binding Test: This is a highly accurate blood test (using a technique called flow cytometry) and is considered a gold standard for diagnosing HS in newborns [9]. However, if a baby has recently had a blood transfusion, this test may be less reliable because the donor’s normal red blood cells can mask the results.
  • Next-Generation Sequencing (NGS): Genetic testing is becoming an increasingly important tool for diagnosing HS [10][11]. NGS looks directly at the baby’s DNA to find mutations in the genes responsible for red blood cell shape (such as the ANK1 gene). A doctor might recommend NGS if the baby’s lab results are atypical, if the symptoms are unusually severe, or to provide a definitive diagnosis if a recent blood transfusion prevents accurate EMA testing—since genetic tests check DNA from white blood cells, they are unaffected by packed red blood cell transfusions [10][12].

What to Watch for After Leaving the Hospital

Even after the severe jaundice has been successfully treated and the baby goes home, the underlying hereditary spherocytosis remains. Parents should be aware that the accelerated breakdown of red blood cells will continue.

Often, between 2 to 8 weeks of age, babies with HS can develop significant anemia (a low red blood cell count) [13]. This happens because their bone marrow has not yet ramped up production to replace the red blood cells being destroyed [3]. Parents should watch for signs of anemia—such as unusual paleness, excessive sleepiness, poor feeding, or rapid breathing—and stay in close contact with their pediatrician, as a blood transfusion may be needed during this window [13]. To support the bone marrow in producing new red blood cells, pediatricians will often prescribe a daily folic acid supplement.

While this newborn phase can feel intense and scary, children with hereditary spherocytosis can lead normal, healthy lives with proper monitoring and management.

Common questions in this guide

Why does hereditary spherocytosis cause severe newborn jaundice?
Babies with hereditary spherocytosis experience a rapid breakdown of abnormal red blood cells. This process releases high amounts of bilirubin that a newborn's developing liver cannot process fast enough, leading to severe yellowing of the skin and eyes.
How is jaundice from hereditary spherocytosis different from typical newborn jaundice?
While typical newborn jaundice peaks a few days after birth and clears within two weeks, jaundice from hereditary spherocytosis often appears within the very first 24 hours of life. It can also be much more severe and persist longer than a typical case.
How do doctors test a newborn for hereditary spherocytosis?
Doctors typically use a highly accurate blood test called the EMA binding test. However, if the baby has recently had a blood transfusion, doctors may use Next-Generation Sequencing (NGS) genetic testing instead, because donor blood does not affect DNA results.
What should parents watch for after a baby with hereditary spherocytosis goes home?
Parents should watch for signs of anemia, which often develops when the baby is between 2 to 8 weeks old. Watch closely for unusual paleness, excessive sleepiness, poor feeding, or rapid breathing, and contact your pediatrician immediately if you notice these signs.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How frequently will we need to check my baby's red blood cell count and bilirubin levels in the first two months?
  2. 2.What is our specific bilirubin threshold for concern, and what signs should prompt an immediate trip to the hospital?
  3. 3.If my baby needs a blood transfusion for anemia at home, how will that process work?
  4. 4.Should my partner and I be genetically tested for hereditary spherocytosis or Gilbert syndrome?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Hereditary Spherocytosis in the Neonatal Period: A Case Report.

    Will A, Henderson CA, Jnah AJ, Newberry D

    Neonatal network : NN 2017; (36(5)):280-288 doi:10.1891/0730-0832.36.5.280.

    PMID: 28847351
  2. 2

    Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.

    Cortesi V, Manzoni F, Raffaeli G, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091549.

    PMID: 34573891
  3. 3

    A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.

    Christensen RD, Yaish HM, Gallagher PG

    Pediatrics 2015; (135(6)):1107-14 doi:10.1542/peds.2014-3516.

    PMID: 26009624
  4. 4

    An Infant With Unusually High Unconjugated Hyperbilirubinemia Due to Coexistence of Hereditary Spherocytosis and Gilbert Syndrome.

    Butorac Ahel I, Baraba Dekanic K, Palcevski G, Roganovic J

    Journal of pediatric hematology/oncology 2018; (40(2)):e127-e128 doi:10.1097/MPH.0000000000001025.

    PMID: 29200157
  5. 5

    Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases.

    Jamwal M, Aggarwal A, Kumar V, et al.

    Clinica chimica acta; international journal of clinical chemistry 2016; (458()):51-4.

    PMID: 27108201
  6. 6

    Illuminating Progress: A Comprehensive Review of the Evolution of Phototherapy for Neonatal Hyperbilirubinemia.

    Patel A, Vagha JD, Meshram RJ, et al.

    Cureus 2024; (16(3)):e55608 doi:10.7759/cureus.55608.

    PMID: 38586621
  7. 7

    A single-center experience on exchange transfusion therapy in 123 full-term cases of severe neonatal hyperbilirubinemia in Wuhan.

    Duan L, Gan S, Hu H

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2021; (34(3)):466-472 doi:10.1080/14767058.2020.1844659.

    PMID: 33225794
  8. 8

    Neonatal exchange transfusion: Experience in Korea.

    Kim MS, Chung Y, Kim H, et al.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2020; (59(3)):102730 doi:10.1016/j.transci.2020.102730.

    PMID: 31948914
  9. 9

    Flow Cytometric Test with Eosin-5-Maleimide for a Diagnosis of Hereditary Spherocytosis in a Newborn.

    Fanhchaksai K, Manowong S, Natesirinilkul R, et al.

    Case reports in hematology 2019; (2019()):5925731 doi:10.1155/2019/5925731.

    PMID: 31205791
  10. 10

    A Systematic review on diagnostic methods of red cell membrane disorders in Asia.

    Silva R, Amarasinghe D, Perera S, Premawardhena A

    International journal of laboratory hematology 2022; (44(2)):248-262 doi:10.1111/ijlh.13800.

    PMID: 35068068
  11. 11

    Tokyo-1 Mutation: Hereditary Spherocytosis in a Hispanic Newborn Presenting as Early Onset Severe Hyperbilirubinemia.

    Tan AW, Leung P, Patil UP

    Fetal and pediatric pathology 2018; (37(4)):296-300 doi:10.1080/15513815.2018.1485797.

    PMID: 30207817
  12. 12

    Genetic mutation analysis of hereditary spherocytosis in Guangxi Zhuang Autonomous Region.

    Chen X, Liao L, Wu Y, et al.

    Journal of hematopathology 2023; (16(2)):95-101 doi:10.1007/s12308-023-00545-8.

    PMID: 38175446
  13. 13

    Study on Management of Blood Transfusion Therapy in Patients with Hereditary Spherocytosis.

    Ma S, Tang L, Wu C, et al.

    Applied bionics and biomechanics 2022; (2022()):6228965 doi:10.1155/2022/6228965.

    PMID: 35126660

This page explains the relationship between severe newborn jaundice and hereditary spherocytosis for educational purposes. Always consult your pediatrician immediately if your baby has severe jaundice or signs of anemia.

Get notified when new evidence is published on Hereditary spherocytosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.